EUVIMEDEUVIMED entdecken
Crossref

KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients

Fangcen Liu, Qin Wang, Yishan Li, Lin Li, Jiaochun Shi, Xiangshan Fan, Qiuyue Pan, Rutian Li iD

Journal of Gastroenterology and Hepatology · 2023

DOI: 10.1111/jgh.16165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Fangcen Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Gastrointestinal Stromal Tumors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Natural Science Foundation of China, Primary Research and Development Plan of Jiangsu Province, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor with high prevalence of KIT and PDGFRA mutations. Few effective treatments can be exploited in imatinib or sunitinib resistant cases. While in immunotherapy, application of the highly individualized cancer neoantigen vaccines is hampered due to high economic and time cost. In this study we identified the most frequent mutation in Chinese GIST patients and predicted candidate neopeptide by next generation sequencing (NGS).

Methods

Tumor tissues and matched blood samples of 116 Chinese GIST patients were collected. Genomic profile was detected through NGS, and 450 cancer genes were deeply sequenced. KIT mutations were identified, and long peptides containing the mutation were queried in NetMHCpan 4.0 tools to predict MHC class I binding of mutant peptides.

Results

The most frequent mutated genes in detected GIST patients were KIT (81.9%, 95/116), CDKN2A (18.97%, 22/116), and CDKN2B (15.52%, 18/116) in this cohort. The most common mutation of KIT was A502_Y503 duplication (15.93%, 18/113) in exon 9. Among the 116 cases, 103 were HLA I genotyped, and 101 were HLA II genotyped. In total, 16 samples with the mutation of KIT p.A502_Y503dup were identified to produce neoantigens with qualified HLA affinity.

Conclusions

KIT hotspot mutation (p.A502_Y503dup) has the highest incidence, which may further eliminate the need for whole genome sequencing and patient‐specific neoantigen prediction and synthesis. Therefore, for those carrying such mutation, accounting for around 16% of Chinese GIST patients and are usually less sensitive to imatinib, effective immunotherapies are in prospect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsGastrointestinal Stromal TumorsHumansEast Asian PeopleImatinib MesylateMutationProto-Oncogene Proteins c-kitSunitinibCyclin-Dependent Kinase Inhibitor p15

Stichwörter der Autor:innen

KITgastrointestinal stromal tumorneoantigen peptide predictionneoantigen vaccine

Substanzen

Antineoplastic AgentsImatinib MesylateProto-Oncogene Proteins c-kitSunitinibCyclin-Dependent Kinase Inhibitor p15

Autor:innen und Institutionen

  • Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School and Clinical Cancer Institute of Nanjing University, Nanjing, China.
  • Shanghai OrigiMed Co., Ltd, Shanghai, China.

ORCID-Profile: Rutian Li

Förderung

  • Natural Science Foundation of China
  • Primary Research and Development Plan of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Jiangsu Provincial Key Research and Development Program

Zitieren

APA

Liu, F., Wang, Q., Li, Y., Li, L., Shi, J., Fan, X., Pan, Q., & Li, R. (2023). KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16165

Vancouver

Liu F, Wang Q, Li Y, Li L, Shi J, Fan X, et al. KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16165

BibTeX
@article{Liu2023,
  author = {Liu, Fangcen and Wang, Qin and Li, Yishan and Li, Lin and Shi, Jiaochun and Fan, Xiangshan and Pan, Qiuyue and Li, Rutian},
  title = {KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1111/jgh.16165}
}
Kostenlos starten →